The bioprocess bags market was valued at $3.3 billion in 2023, and is projected to reach $14.9 billion by 2033, growing at a CAGR of 16.4% from 2024 to 2033.
Bioprocess bag is a single-use, high-performance bag that is made from high-grade polymers, making it compatible for a wide range of bioprocessing applications such as storage, handling, and transportation of biopharmaceutical fluids, including cell cultures, media, buffers, and other critical materials. These bags are designed to maintain the sterility and reduce the risk of cross-contamination. Their use is rapidly expanding due to the growing demand for single-use technologies, which offer increased efficiency and superior operational flexibility.
The growth of the global bioprocess bags market is majorly driven by surge in demand for biopharmaceuticals, such as vaccines, monoclonal antibodies, and cell therapies as well as increase in adoption of single-use technologies due to their cost-effectiveness and reduced risk of contamination. Studies have shown that the use of bioprocess bags in cell culture processes can reduce the risk of cross-contamination by over 90% compared to traditional stainless steel systems, due to their single-use nature and elimination of complex cleaning procedures. Furthermore, bioprocess bags offer lower capital and operational costs compared to traditional stainless steel systems, including reduced cleaning and validation requirements, which acts as a key driving force of the global market. Moreover, multiple benefits associated with these bags augment the market growth; for instance, they allow for easy and quick scalability in biomanufacturing processes, which is crucial in meeting the growing demand for biologics and personalized medicines. In addition, the demand for vaccines and other biopharmaceutical products, spurred by global health challenges like pandemics, has increased the reliance on bioprocess bags for efficient production and distribution. The industry is shifting toward the use of sustainable and eco-friendly materials for bioprocess bags, driven by the need to reduce environmental impact and improve the overall sustainability of biomanufacturing processes, which is expected to notably contribute toward the market growth. However, generation of generates a significant amount of plastic waste due to single-use bioprocess bags coupled with rise in concerns about environmental impact and increase in pressure for sustainable disposal methods hamper the market growth. Moreover, potential risk associated with contamination of products due to leachable and extractables from the polymer materials used in bioprocess bags restrain the use of bioprocess bags. On the contrary, continuous advancements in the materials and design of bioprocess bags, such as improved barrier properties and compatibility with a broader range of bioprocessing applications, are expected to offer lucrative opportunities for the market growth during the forecast period. In addition, manufacturers are focusing on improving sterility and maintaining product integrity of bioprocess bags, which will address the critical need for contamination-free production in high-value biologics. Such developments are anticipated to open new avenues for the market growth.
The global bioprocess bags industry is segmented into type, workflow, end user, and region. On the basis of type, the market is bifurcated into 2D bioprocess bags, 3D bioprocess bags, and others. By workflow, it is divided into upstream process, downstream process, and process development. Depending on end user, it is segregated into pharmaceutical & biopharmaceutical companies, CMOs & CROs, and academic & research institute. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of workflow, the upstream process segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, pharmaceutical & biotechnology companies is projected to emerge as the leading segment in the coming years.
Region wise, North America held the largest market share, in terms of revenue, in 2023, and is expected to dominate the market during the forecast period.
Bioprocess bag is a single-use, high-performance bag that is made from high-grade polymers, making it compatible for a wide range of bioprocessing applications such as storage, handling, and transportation of biopharmaceutical fluids, including cell cultures, media, buffers, and other critical materials. These bags are designed to maintain the sterility and reduce the risk of cross-contamination. Their use is rapidly expanding due to the growing demand for single-use technologies, which offer increased efficiency and superior operational flexibility.
The growth of the global bioprocess bags market is majorly driven by surge in demand for biopharmaceuticals, such as vaccines, monoclonal antibodies, and cell therapies as well as increase in adoption of single-use technologies due to their cost-effectiveness and reduced risk of contamination. Studies have shown that the use of bioprocess bags in cell culture processes can reduce the risk of cross-contamination by over 90% compared to traditional stainless steel systems, due to their single-use nature and elimination of complex cleaning procedures. Furthermore, bioprocess bags offer lower capital and operational costs compared to traditional stainless steel systems, including reduced cleaning and validation requirements, which acts as a key driving force of the global market. Moreover, multiple benefits associated with these bags augment the market growth; for instance, they allow for easy and quick scalability in biomanufacturing processes, which is crucial in meeting the growing demand for biologics and personalized medicines. In addition, the demand for vaccines and other biopharmaceutical products, spurred by global health challenges like pandemics, has increased the reliance on bioprocess bags for efficient production and distribution. The industry is shifting toward the use of sustainable and eco-friendly materials for bioprocess bags, driven by the need to reduce environmental impact and improve the overall sustainability of biomanufacturing processes, which is expected to notably contribute toward the market growth. However, generation of generates a significant amount of plastic waste due to single-use bioprocess bags coupled with rise in concerns about environmental impact and increase in pressure for sustainable disposal methods hamper the market growth. Moreover, potential risk associated with contamination of products due to leachable and extractables from the polymer materials used in bioprocess bags restrain the use of bioprocess bags. On the contrary, continuous advancements in the materials and design of bioprocess bags, such as improved barrier properties and compatibility with a broader range of bioprocessing applications, are expected to offer lucrative opportunities for the market growth during the forecast period. In addition, manufacturers are focusing on improving sterility and maintaining product integrity of bioprocess bags, which will address the critical need for contamination-free production in high-value biologics. Such developments are anticipated to open new avenues for the market growth.
The global bioprocess bags industry is segmented into type, workflow, end user, and region. On the basis of type, the market is bifurcated into 2D bioprocess bags, 3D bioprocess bags, and others. By workflow, it is divided into upstream process, downstream process, and process development. Depending on end user, it is segregated into pharmaceutical & biopharmaceutical companies, CMOs & CROs, and academic & research institute. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the 2D bioprocess bags segment is expected to dominate the market from 2024 to 2033.On the basis of workflow, the upstream process segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, pharmaceutical & biotechnology companies is projected to emerge as the leading segment in the coming years.
Region wise, North America held the largest market share, in terms of revenue, in 2023, and is expected to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global bioprocess bags market include Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Saint-Gobain Performance Plastics., Lonza Group AG, Eppendorf AG, Meissner Filtration Products, Inc., PBS Biotech, Inc., and GE Healthcare. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Additional company profiles with specific to client's interest
- Expanded list for Company Profiles
Key Market Segments
By Type
- 2D bioprocess bags
- 3D bioprocess bags
- Others
By Workflow
- Upstream Process
- Downstream Process
- Process Development
By End User
- Pharmaceutical and Biopharmaceutical Companies
- CMOs and CROs
- Academic and Research Institute
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- Danaher Corporation
- Saint-Gobain Performance Plastics.
- Lonza Group AG
- Eppendorf AG
- Meissner Filtration Products, Inc.
- PBS Biotech, Inc.
- GE Healthcare
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: BIOPROCESS BAGS MARKET, BY TYPE
CHAPTER 5: BIOPROCESS BAGS MARKET, BY WORKFLOW
CHAPTER 6: BIOPROCESS BAGS MARKET, BY END USER
CHAPTER 7: BIOPROCESS BAGS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Key Market Players in the Bioprocess Bags Market include:- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- Danaher Corporation
- Saint-Gobain Performance Plastics.
- Lonza Group AG
- Eppendorf AG
- Meissner Filtration Products, Inc.
- PBS Biotech, Inc.
- GE Healthcare
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 260 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 3.3 billion |
| Forecasted Market Value ( USD | $ 14.9 billion |
| Compound Annual Growth Rate | 16.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
